Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane

Angiogenesis

Volumn 13, Issue 4, 2010, Pages 281-292

  Nowak Sliwinska, Patrycja ^a   Van Beijnum, Judy R ^b   Van Berkel, Maaike ^b   Van Den Bergh, Hubert ^a   Griffioen, Arjan W ^b  

^a EPFL   (Switzerland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Avastin ; Capillary; Galectin 1; Photodynamic therapy; Real time RT PCR; VEGF; Vimentin; Visudyne

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA3 INTEGRIN; BEVACIZUMAB; CYCLOPHILIN A; GALECTIN 1; INTERCELLULAR ADHESION MOLECULE 1; KI 67 ANTIGEN; NEUROPILIN 2; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VERTEPORFIN; VIMENTIN; VITRONECTIN RECEPTOR; ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN; MONOCLONAL ANTIBODY; PHOTOSENSITIZING AGENT; PORPHYRIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTERY BLOOD FLOW; ARTICLE; CELL PROLIFERATION; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; EPIFLUORESCENCE MICROSCOPY; GENE CONTROL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VASCULARIZATION; VASOCONSTRICTION; ANIMAL; BLOOD VESSEL; CHICK EMBRYO; DRUG EFFECT; EVALUATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHOTOCHEMOTHERAPY;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD VESSELS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; GENE EXPRESSION REGULATION; NEOVASCULARIZATION, PHYSIOLOGIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TRANSCRIPTION, GENETIC;

EID: 79952279701     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-010-9185-x     Document Type: Article

References (54)

1. Radu A, Wagnieres G, van den Bergh H, Monnier P (2000) Photodynamic therapy of early squamous cell cancers of the esophagus. Gastrointest Endosc Clin N Am 10(3):439-460 (Pubitemid 30429685)
2. van den Bergh H, Ballini JP (2003) Photodynamic therapy: basic principle. In: FFaK S (ed) Lasers in ophthalmology - basic, diagnostic and surgical aspects. Kugler Publications, The Hague, pp 183-195
3. Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55(1):145-157
4. Hopper C (2000) Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1:212-219
5. Star WM, Marijnissen HP, van den Berg-Blok AE, Versteeg JA, Franken KA, Reinhold HS (1986) Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 46(5):2532-2540 (Pubitemid 16120726)
6. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, Dougherty TJ (1985) Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 45(2):572-576 (Pubitemid 15161049)
7. Selman SH, Kreimer-Birnbaum M, Klaunig JE, Goldblatt PJ, Keck RW, Britton SL (1984) Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res 44(5):1924-1927 (Pubitemid 14145133)
8. Reed MW, Schuschke DA, Miller FN (1991) Prostanoid antagonists inhibit the response of the microcirculation to "early" photodynamic therapy. Radiat Res 127(3):292-296
9. Chan WM, Lim TH, Pece A, Silva R, Yoshimura N (2010) Verteporfin PDT for non-standard indications - a review of current literature. Graefes Arch Clin Exp Ophthalmol 248(5):613-626
10. Hendrich C, Huttmann G, Vispo-Seara JL, Houserek S, Siebert WE (2000) Experimental photodynamic laser therapy for rheumatoid arthritis with a second generation photosensitizer. Knee Surg Sports Traumatol Arthrosc 8(3):190-194
11. Choudhary S, Nouri K, Elsaie ML (2009) Photodynamic therapy in dermatology: a review. Lasers Med Sci 24(6):971-980
12. O'Connor AE, Gallagher WM, Byrne AT (2009) Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 85(5):1053-1074
13. Ishiwata I, Ishiwata C, Soma M, Ono I, Nakaguchi T, Ishikawa H (1988) Tumor angiogenic activity of gynecologic tumor cell lines on the chorioallantoic membrane. Gynecol Oncol 29(1):87-93
14. Debefve E, Pegaz B, Ballini JP, van den Bergh H (2009) Combination therapy using verteporfin and ranibizumab; optimizing the timing in the CAM model. Photochem Photobiol 85(6):1400-1408
15. Debefve E, Pegaz B, van den Bergh H, Wagnieres G, Lange N, Ballini JP (2008) Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis 11(3):235-243
16. Pegaz B, Debefve E, Ballini JP, Wagnieres G, Spaniol S, Albrecht V et al (2006) Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Eur J Pharm Sci 28(1-2):134-140
17. Lim SH, Nowak-Sliwinska P, Kamarulzaman FA, van den Bergh H, Wagnieres G, Lee HB. (2010) The Neovessel Occlusion Efficacy of 15-Hydroxypurpurin-7-Lactone Dimethyl Ester Induced with Photodynamic Therapy. Photochem Photobiol
18. Hasan J, Shnyder SD, Bibby M, Double JA, Bicknel R, Jayson GC (2004) Quantitative angiogenesis assays in vivo-a review. Angiogenesis 7(1):1-16 (Pubitemid 39127766)
19. Lobrinus JA, Juillerat-Jeanneret L, Darekar P, Schlosshauer B, Janzer RC (1992) Induction of the blood-brain barrier specific HT7 and neurothelin epitopes in endothelial cells of the chick chorioallantoic vessels by a soluble factor derived from astrocytes. Brain Res Dev Brain Res 70(2):207-211 (Pubitemid 23003768)
20. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V (2001) Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 264(4):317-324 (Pubitemid 33097031)
21. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ (2000) Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 60(15):4066-4069 (Pubitemid 30636586)
22. Ju M, Mailhos C, Bradley J, Dowie T, Ganley M, Cook G et al (2008) Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization. Invest Ophthalmol Vis Sci 49(2):662-670
23. Zuluaga MF, Lange N (2008) Combination of photodynamic therapy with anti-cancer agents. Curr Med Chem 15(17):1655-1673
24. Petermeier K, Tatar O, Inhoffen W, Volker M, Lafaut BA, Henke-Fahle S et al (2006) Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes. Br J Ophthalmol 90(8):1034-1039 (Pubitemid 44140188)
25. Lim SH, Thivierge C, Nowak-Sliwinska P, Han J, van den Bergh H, Wagnieres G et al (2010) In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy. J Med Chem 53(7):2865-2874
26. Nowak-Sliwinska P, Karocki A, Elas M, Pawlak A, Stochel G, Urbanska K (2006) Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells. Biochem Biophys Res Commun 349(2):549-555 (Pubitemid 44344555)
27. Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO (2003) Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium- derived factor. Invest Ophthalmol Vis Sci 44(10): 4473-4480 (Pubitemid 37186285)
28. Beckstead JH (1995) A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues: addendum. J Histochem Cytochem 43(3):345
29. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45
30. Nowak-Sliwinska P, Ballini JP, Wagnieres G, van den Bergh H (2010) Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model. Microvasc Res 79(1):21-28
31. van Beijnum JR, Dings RP, van der Linden E, Zwaans BM, Ramaekers FC, Mayo KH et al (2006) Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood 108(7):2339-2348 (Pubitemid 44497518)
32. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S et al (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103(43):15975-15980 (Pubitemid 44657577)
33. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G (1996) Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res 56(5):1111-1117 (Pubitemid 26065408)
34. Pegaz B, Debefve E, Ballini JP, Konan-Kouakou YN, van den Bergh H (2006) Effect of nanoparticle size on the extravasation and the photothrombic activity of meso(p-tetracarboxyphenyl) porphyrin. J Photochem Photobiol B 85(3):216-222 (Pubitemid 44567380)
35. Pegaz B, Debefve E, Borle F, Ballini JP, van den Bergh H, Kouakou-Konan YN (2005) Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study. J Photochem Photobiol B 80(1):19-27 (Pubitemid 40823836)
36. Pegaz B, Debefve E, Borle F, Ballini JP, Wagnieres G, Spaniol S et al (2005) Preclinical evaluation of a novel water-soluble chlorin E6 derivative (BLC 1010) as photosensitizer for the closure of the neovessels. Photochem Photobiol 81(6):1505-1510 (Pubitemid 43035864)
37. Biel MA (2007) Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 83(5):1063-1068 (Pubitemid 47438525)
38. Grosjean P, Wagnieres G, Fontolliet C, van den Bergh H, Monnier P (1998) Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer 77(11):1989-1995 (Pubitemid 28254645)
39. Arroyo JG, Michaud N, Jakobiec FA (2003) Choroidal neovascular membranes treated with photodynamic therapy. Arch Ophthalmol 121(6):898-903 (Pubitemid 36676231)
40. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 93(25):14765-14770 (Pubitemid 26419043)
41. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6): 1163-1177 (Pubitemid 36870177)
42. Flamme I, von Reutern M, Drexler HC, Syed-Ali S, Risau W (1995) Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol 171(2):399-414
43. Zuluaga MF, Mailhos C, Robinson G, Shima DT, Gurny R, Lange N (2007) Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration. Invest Ophthalmol Vis Sci 48(4):1767-1772 (Pubitemid 351261364)
44. Ley CD, Olsen MW, Lund EL, Kristjansen PE (2004) Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay. Microvasc Res 68(3):161-168 (Pubitemid 40288112)
45. Schmidt-Erfurth U, Hasan T (2000) Mechanisms of action of photodynamic therapy with verteporfin for the treatment of agerelated macular degeneration. Surv Ophthalmol 45(3):195-214
46. Tatar O, Adam A, Shinoda K, Stalmans P, Eckardt C, Luke M et al (2006) Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy. Am J Ophthalmol 142(1):95-104
47. Uehara M, Inokuchi T, Sano K, Zuo Lin W (2001) Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy. Eur J Cancer 37(16):2111-2115 (Pubitemid 32938117)
48. Togashi H, Uehara M, Ikeda H, Inokuchi T (2006) Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft. Oral Oncol 42(5):526-532
49. Chang SK, Rizvi I, Solban N, Hasan T (2008) In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin Cancer Res 14(13):4146-4153
50. Bhuvaneswari R, Thong PS, Gan YY, Soo K, Olivo M (2010) Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy. J Biomed Opt 15(1):011114
51. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G et al (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79(7):1157-1164
52. Prasad SC, Thraves PJ, Kuettel MR, Srinivasarao GY, Dritschilo A, Soldatenkov VA (1998) Apoptosis-associated proteolysis of vimentin in human prostate epithelial tumor cells. Biochem Biophys Res Commun 249(2):332-338 (Pubitemid 28431753)
53. Belichenko I, Morishima N, Separovic D (2001) Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in Jurkat cells. Arch Biochem Biophys 390(1):57-63 (Pubitemid 32493570)
54. Nowak-Sliwinska P, Wagnieres G, van den Bergh H, Griffioen AW (2010) Angiostasis-induced vascular normalization can improve photodynamic therapy. Cell Mol Life Sci 67(9):1559-1560